oxybutynin has been researched along with tamsulosin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Aquilina, JW; Armstrong, RB; Chen, A; MacDiarmid, SA; Nitti, VW; Orman, C; Peters, KM | 1 |
| Abbadie, C; Degenhardt, A; Gichuru, L; Jochnowitz, N; Mistry, SL; Nagabukuro, H; Villa, KL | 1 |
| Blak, B; Hakimi, Z; Johnson, M; Nazir, J; Odeyemi, IA | 1 |
| Bridgeman, MB; Dalal, KS | 1 |
| Barkin, J; Berner, T; Diles, D; Franks, B | 1 |
| Schaeffer, EM | 1 |
| Fralick, M; Jung, EH; Kesselheim, AS; Schneeweiss, S; Wallis, CJD | 1 |
| Ayyash, O; Bandari, J; Davies, BJ; Jacobs, BL; Kumar, P; Macleod, LC; Odisho, AY; Ogunmola, AG; Sabik, LM; Shah, AA; Yabes, JG | 1 |
| Agarwal, D; Assmus, M; Krambeck, AE; Large, T; Lee, MS; Rivera, ME | 1 |
| Lee, G; Reismann, S | 1 |
| Alhaj, SA; Assaf, SM; Ghanem, AM; Khalil, EA; Sallam, AA | 1 |
1 review(s) available for oxybutynin and tamsulosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for oxybutynin and tamsulosin
| Article | Year |
|---|---|
Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study.
Topics: Aged; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics | 2008 |
13 other study(ies) available for oxybutynin and tamsulosin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Correlation between pharmacologically-induced changes in cystometric parameters and spinal c-Fos expression in rats.
Topics: Animals; Dioxoles; Female; Gene Expression Regulation; Mandelic Acids; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Spinal Cord; Sulfonamides; Tamsulosin; Urinary Bladder; Urination | 2010 |
Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzhydryl Compounds; Cresols; Family Practice; Humans; Lower Urinary Tract Symptoms; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Primary Health Care; Prostatic Hyperplasia; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Tolterodine Tartrate; United Kingdom | 2015 |
Drugs for urologic disorders.
Topics: Acetanilides; Azasteroids; Drug Combinations; Dutasteride; Ferric Compounds; Gels; Humans; Injections; Maltose; Mandelic Acids; Sulfonamides; Tamsulosin; Thiazoles; Urologic Diseases; Urological Agents | 2015 |
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Mandelic Acids; Medication Adherence; Middle Aged; Muscarinic Antagonists; Ontario; Prazosin; Prostatic Hyperplasia; Prostatism; Pyrrolidines; Quinazolines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate | 2015 |
Re: Efficacy of Tamsulosin, Oxybutynin, and Their Combination in the Control of Double-J Stent-Related Lower Urinary Tract Symptoms.
Topics: Humans; Lower Urinary Tract Symptoms; Mandelic Acids; Stents; Tamsulosin | 2018 |
Desmopressin and the risk of hyponatremia: A population-based cohort study.
Topics: Administration, Intranasal; Aged; Aged, 80 and over; Cohort Studies; Deamino Arginine Vasopressin; Female; Hemostatics; Humans; Hyponatremia; Male; Mandelic Acids; Middle Aged; Nocturia; Propensity Score; Proportional Hazards Models; Risk Factors; Tamsulosin; Treatment Outcome | 2019 |
Statewide Price Variation for Generic Benign Prostatic Hyperplasia Medications.
Topics: Costs and Cost Analysis; Drugs, Generic; Finasteride; Humans; Male; Mandelic Acids; Pennsylvania; Prostatic Hyperplasia; Tamsulosin | 2021 |
Opioid Free Ureteroscopy: What is the True Failure Rate?
Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Diclofenac; Drug Prescriptions; Female; Humans; Kidney Calculi; Male; Mandelic Acids; Middle Aged; Pain, Postoperative; Phenazopyridine; Retrospective Studies; Tamsulosin; Ureteroscopy | 2021 |
Assessment of a five-layer laminate technique to measure the saturation solubility of drug in pressure-sensitive adhesive film.
Topics: Adhesives; Administration, Cutaneous; Adrenergic alpha-1 Receptor Antagonists; Crystallization; Diffusion; Kinetics; Microscopy; Pressure; Solubility; Sulfonamides; Tamsulosin; Technology, Pharmaceutical; Transdermal Patch | 2012 |
Formulation and Evaluation of Eudragit® RL Polymeric Double Layer Films for Prolonged-Release Transdermal Delivery of Tamsulosin Hydrochloride.
Topics: Administration, Cutaneous; Drug Delivery Systems; Polymers; Polymethacrylic Acids; Skin; Tamsulosin; Transdermal Patch | 2022 |